The World Health Organization has just published its first list of priority pathogens, drawing attention to the rising global threat of antibiotic resistant bacteria, also called superbugs. “The emergence and spread of multi-drug resistant bacteria is a serious global health challenge,” notes Dr. Miriam Rabkin, director for health systems strategies at ICAP. “The concern is that if these multi-drug resistant organisms continue to spread, we will run out of working antibiotics. It’s a terrifying scenario.”
This World TB Day, ICAP and its partners around the world are rallying behind the global campaign to “Unite to End TB.” The World Health Organization has called for a special focus on uniting efforts to leave no one behind, a theme exemplified by ICAP’s work to make TB and HIV services accessible to Lesotho’s hard-to-reach migrant miners.
ICAP researchers collaborated with the Eastern Cape Department of Health in South Africa in the assessment of the role of community health workers in the Re-engineering Primary Health Care Initiative, a national effort to decentralize primary health services to the community level. Findings of the study were recently published online in the journal PLoS ONE.
The first “Population-based HIV Impact Assessment (PHIA)” survey results, released in late 2016, demonstrate the remarkable progress that has been made confronting the HIV epidemic in Malawi, Zambia, and Zimbabwe. The survey results also provide some of the first national HIV incidence estimates based on household-level data collected in these countries. The importance of this type of data and the feasibility of conducting such studies was first demonstrated by an earlier project, the 2011 Swaziland HIV Incidence Measurement Survey (SHIMS), the results of which were recently published in The Lancet HIV.
This International Women’s Day, the world pledges to take bold action to accelerate gender parity. Globally, there are nearly 18 million women living with HIV, constituting 51 percent of all adults living with HIV. Far too often, women face disproportionate cultural, social, and economic barriers to accessing the HIV prevention, care, and treatment services they need.
Differentiated service delivery has the potential to improve both the quality and efficiency of HIV programs. Leading the charge toward a new future of high quality, high impact, and sustainable HIV programs, ICAP is looking at ways to measure the scale-up and spread of differentiated care, not presently captured by traditional monitoring and evaluation approaches.